{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.Clinicalstudies.in/SOP-for-Genetic-Sample-Consent-and-Data-Use”
},
“headline”: “SOP for Genetic Sample Consent and Data Use in Clinical Trials”,
“description”: “This SOP describes regulatory-compliant procedures for obtaining informed consent for genetic sample collection, storage, and data use in clinical trials, aligned with ICH GCP, FDA, EMA, CDSCO, and WHO guidelines.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}
Published on 22/12/2025
Standard Operating Procedure for Genetic Sample Consent and Data Use
| Department | Clinical Research |
| SOP No. | CR/ICF/016/2025 |
| Supersedes | NA |
| Page No. | 1 of 24 |
| Issue Date | 26/08/2025 |
| Effective Date | 01/09/2025 |
| Review Date | 01/09/2026 |
Purpose
The purpose of this SOP is to provide detailed instructions for obtaining informed consent for genetic sample collection, storage, and data use in
Scope
This SOP applies to all investigators, study staff, biobank managers, and data protection officers involved in trials where genetic samples (blood, saliva, tissue, DNA/RNA) are collected. It covers both primary and secondary use of genetic material and applies to international multi-center trials.
Responsibilities
- Principal Investigator (PI): Ensures that participants are fully informed of genetic sample use and that consent is obtained before collection.
- Study Coordinator: Manages sample labeling, anonymization/pseudonymization, and storage processes.
- Data Protection Officer: Ensures compliance with data privacy regulations (GDPR, HIPAA, CDSCO rules).
- Ethics Committee/IRB: Reviews and approves consent language and safeguards for genetic data use.
- Quality Assurance Officer: Verifies compliance during audits and inspections.
Accountability
The Principal Investigator and sponsor are accountable for ensuring that genetic sample consent procedures comply with ethical standards, participant rights, and applicable regulatory guidelines. Improper consent or misuse of genetic data may result in ethical violations and legal liability.
Procedure
1. Preparation of Genetic Consent Form
Draft a separate section in the Informed Consent Form (ICF) explaining genetic sample collection, use, and data storage.
Include details of possible future use, anonymization, data sharing, and retention.
Obtain EC/IRB approval for consent form before use.
2. Participant Information and Counseling
Provide clear explanation of why genetic samples are collected and how they will be used.
Discuss risks such as privacy breaches, potential misuse, or incidental findings.
Inform participants of their right to decline genetic testing while still participating in the trial (if applicable).
3. Obtaining Consent
Obtain written consent for genetic sample collection and use.
Obtain specific consent for secondary use of genetic material in future studies.
Record participant’s preferences regarding data sharing with international repositories.
4. Sample Handling and Anonymization
Label samples with coded identifiers, not participant names.
Maintain a linkage file securely stored and accessible only to authorized personnel.
Follow biosafety procedures for collection, storage, and transport.
5. Data Privacy and Security
Store genetic data in encrypted systems with access controls.
Comply with applicable regulations such as GDPR, HIPAA, and CDSCO privacy laws.
Ensure cross-border data transfers meet international standards.
6. Withdrawal of Consent
Allow participants to withdraw consent for genetic sample use at any stage.
Destroy or anonymize withdrawn samples where feasible.
Document withdrawal in Consent Documentation Log.
7. Record Keeping
File consent forms in Trial Master File (TMF).
Maintain sample tracking logs, data storage logs, and destruction records.
Abbreviations
- SOP: Standard Operating Procedure
- PI: Principal Investigator
- ICF: Informed Consent Form
- EC: Ethics Committee
- IRB: Institutional Review Board
- GDPR: General Data Protection Regulation
- HIPAA: Health Insurance Portability and Accountability Act
- TMF: Trial Master File
Documents
- Genetic Sample Consent Form (Annexure-1)
- Sample Tracking Log (Annexure-2)
- Data Use Agreement Template (Annexure-3)
References
- ICH E6(R2) – Good Clinical Practice
- US FDA – Genomic Research Guidance
- EMA Clinical Trial Regulation (EU No. 536/2014)
- CDSCO Clinical Trial Rules, 2019
- WHO – Guidance on Ethics in Health Research
Version: 1.0
Approval Section
| Prepared By | Rajesh Kumar, Clinical Research Coordinator |
| Checked By | Sunita Reddy, QA Officer |
| Approved By | Dr. Anil Sharma, Principal Investigator |
Annexures
Annexure-1: Genetic Sample Consent Form
| Participant ID | Consent for Genetic Testing | Consent for Future Use | Date | Investigator |
|---|---|---|---|---|
| PAT-041 | Yes | No | 12/09/2025 | Dr. Meera Joshi |
Annexure-2: Sample Tracking Log
| Date | Sample ID | Type | Status | Storage Location |
|---|---|---|---|---|
| 14/09/2025 | SMP-101 | Blood | Stored | Freezer A-2 |
Annexure-3: Data Use Agreement Template
| Institution | Data Type | Use Purpose | Confidentiality Clause | Approval |
|---|---|---|---|---|
| XYZ Biobank | DNA Sequence | Genomic Analysis | Yes | Signed |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
|---|---|---|---|---|
| 26/08/2025 | 00 | Initial version | New SOP creation | Head, Clinical Research |
For more SOPs visit: Pharma SOP